Insights On Partnering
-
Patient-Focused Strategies For Long-Term Follow-Up In Gene Therapies
7/2/2024
As the landscape evolves, sponsors must adopt innovative, patient-centered approaches and technologies to effectively conduct LTFU studies, minimizing the burden on patients and research sites.
-
Outsourcing High Potent OSD Late-Stage Development: CDMO Insights
4/17/2024
View the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle and deliver their product to clinic and to market.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
1/6/2025
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Five Ways Site-Facing Technology Helps Sponsors And CROs
4/17/2025
Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
7/23/2024
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
Cutting-Edge Tech Improving Global Participant Payment Paradigms
12/13/2024
Participant payment management is essential for successful global clinical trials, as it enables diverse regulatory compliance, enhances participant satisfaction, and streamlines execution.
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover
6/7/2024
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials
6/19/2024
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology
5/14/2025
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
-
Accelerate Drug Development With Master Protocols
5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.